Companies / Entasis Therapeutics Holdings Inc.
Entasis Therapeutics Holdings Inc.
ETTXCIK 1724344
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 11, 2022 | Theravance Inc 10% owner | Buy Open-market buy | Common Stock | $16.72M | +7.6M +35.06% | 29,270,476 | high |
| Jun 11, 2021 | Theravance Inc 10% owner | Buy Open-market buy | Common Stock | $12.54M | +6.3M +168.02% | 10,000,000 | high |
| May 3, 2021 | Theravance Inc 10% owner | Buy Open-market buy | Common Stock | $7.46M | +3.7M | 3,731,025 | high |
| Jul 7, 2022 | Perros Manoussos Executive | Other Shares tendered | Common Stock | $123.4K | -56K -100.00% | 0 | low |
| Jul 7, 2022 | Tommasi Ruben Executive | Other Shares tendered | Common Stock | $87.1K | -40K -100.00% | 0 | low |
| Jul 11, 2022 | Meek David D. Director | Other Sold to issuer | Common Stock | $60.5K | -28K -100.00% | 0 | low |
| Jul 11, 2022 | Mayer Howard Director | Other Sold to issuer | Common Stock | $60.5K | -28K -100.00% | 0 | low |
| Jul 11, 2022 | Hastings David C Director | Other Sold to issuer | Common Stock | $60.5K | -28K -100.00% | 0 | low |